361 related articles for article (PubMed ID: 20491344)
21. Long-term, low-dose azithromycin treatment reduces the incidence but increases macrolide resistance in Staphylococcus aureus in Danish CF patients.
Hansen CR; Pressler T; Hoiby N; Johansen HK
J Cyst Fibros; 2009 Jan; 8(1):58-62. PubMed ID: 18849202
[TBL] [Abstract][Full Text] [Related]
22. Discrepancy between antibiotics administered in acute exacerbations of chronic bronchitis and susceptibility of isolated pathogens in respiratory samples: multicentre study in the primary care setting.
Querol-Ribelles JM; Molina J; Naberan K; Esteban E; Herreras A; Garcia-de-Lomas J
Int J Antimicrob Agents; 2006 Nov; 28(5):472-6. PubMed ID: 17046209
[TBL] [Abstract][Full Text] [Related]
23. [Correlation between pulmonary pharmacokinetics and pharmacodynamics support the hypothesis of the usefulness of ceftazidime at a single 1g daily dose in the treatment of bacterial exacerbation of chronic obstructive bronchopneumonia with moderate functional damage].
Cazzola M; Noschese P; Vinciguerra A; Di Perna F; Califano C; Berra A
Minerva Med; 1998; 89(1-2):15-22. PubMed ID: 9561021
[TBL] [Abstract][Full Text] [Related]
24. [Infections in chronic obstructive pulmonery disease].
Leophonte P
Bull Acad Natl Med; 2004; 188(1):47-64; discussion 64-6. PubMed ID: 15368925
[TBL] [Abstract][Full Text] [Related]
25. Pseudomonas aeruginosa in adults with chronic obstructive pulmonary disease.
Murphy TF
Curr Opin Pulm Med; 2009 Mar; 15(2):138-42. PubMed ID: 19532029
[TBL] [Abstract][Full Text] [Related]
26. [Pseudomonas aeruginosa in chronic obstructive pulmonary disease].
Wavre-Oberhänsli A; Nicod LP
Rev Med Suisse; 2010 Nov; 6(272):2240-3. PubMed ID: 21207736
[TBL] [Abstract][Full Text] [Related]
27. [A clinical study of bacterial infection in patients with chronic obstructive pulmonary disease].
Zhao M; Gu G; Liu Z; Zhang X; Xu W; Fang Q
Zhonghua Jie He He Hu Xi Za Zhi; 1999 Feb; 22(2):88-91. PubMed ID: 11820948
[TBL] [Abstract][Full Text] [Related]
28. Bronchoscopic validation of the significance of sputum purulence in severe exacerbations of chronic obstructive pulmonary disease.
Soler N; Agustí C; Angrill J; Puig De la Bellacasa J; Torres A
Thorax; 2007 Jan; 62(1):29-35. PubMed ID: 16928715
[TBL] [Abstract][Full Text] [Related]
29. Microbiology and management of sinusitis.
Brook I
J Otolaryngol; 1996 Aug; 25(4):249-56. PubMed ID: 8863213
[TBL] [Abstract][Full Text] [Related]
30. Chronic obstructive pulmonary disease: role of bacteria and guide to antibacterial selection in the older patient.
Murphy TF; Sethi S
Drugs Aging; 2002; 19(10):761-75. PubMed ID: 12390053
[TBL] [Abstract][Full Text] [Related]
31. Sputum bacteriology in patients with acute exacerbations of COPD in Hong Kong.
Ko FW; Ng TK; Li TS; Fok JP; Chan MC; Wu AK; Hui DS
Respir Med; 2005 Apr; 99(4):454-60. PubMed ID: 15763452
[TBL] [Abstract][Full Text] [Related]
32. Lower Airway Bacterial Colonization Patterns and Species-Specific Interactions in Chronic Obstructive Pulmonary Disease.
Jacobs DM; Ochs-Balcom HM; Zhao J; Murphy TF; Sethi S
J Clin Microbiol; 2018 Oct; 56(10):. PubMed ID: 30045868
[TBL] [Abstract][Full Text] [Related]
33. Sputum bacteriology in patients hospitalized with acute exacerbations of chronic obstructive pulmonary disease and concomitant pneumonia in Hong Kong.
Ko FW; Lam RK; Li TS; Fok JP; Chan MC; Ng TK; Chan DP; Hui DS
Intern Med J; 2005 Nov; 35(11):661-7. PubMed ID: 16248860
[TBL] [Abstract][Full Text] [Related]
34. Prulifloxacin in the treatment of acute exacerbations of COPD in cigarette smokers.
Pasqua F; Biscione G; Crigna G; Cazzola M
Ther Adv Respir Dis; 2008 Aug; 2(4):209-14. PubMed ID: 19124373
[TBL] [Abstract][Full Text] [Related]
35. [Infectious agents associated with exacerbations of chronic obstructive bronchopneumopathies and asthma attacks].
Philit F; Etienne J; Calvet A; Mornex JF; Trillet V; Aymard M; Brune J; Cordier JF
Rev Mal Respir; 1992; 9(2):191-6. PubMed ID: 1565831
[TBL] [Abstract][Full Text] [Related]
36. Bacteria associated with acute exacerbations of chronic obstructive pulmonary disease requiring mechanical ventilation and antimicrobial management in Respiratory Care Unit of Central Chest Institute of Thailand.
Siripataravanit S; Phaicharoen R; Termsetcharoen S; Klangprapun N
J Med Assoc Thai; 2012 Aug; 95 Suppl 8():S11-8. PubMed ID: 23130469
[TBL] [Abstract][Full Text] [Related]
37. Lower airway bacterial colonization in asymptomatic smokers and smokers with chronic bronchitis and recurrent exacerbations.
Qvarfordt I; Riise GC; Andersson BA; Larsson S
Respir Med; 2000 Sep; 94(9):881-7. PubMed ID: 11001080
[TBL] [Abstract][Full Text] [Related]
38. A prediction model for bacterial etiology in acute exacerbations of COPD.
Lode H; Allewelt M; Balk S; De Roux A; Mauch H; Niederman M; Schmidt-Ioanas M
Infection; 2007 Jun; 35(3):143-9. PubMed ID: 17565454
[TBL] [Abstract][Full Text] [Related]
39. Bacterial exacerbations of chronic obstructive pulmonary disease. The role of lung function in aetiology of exacerbation.
Kieszko R; Szmygin-Milanowska K; Chudnicka A; Gołebiowska I; Łagozna J; Milanowski J
Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):475-80. PubMed ID: 15315034
[TBL] [Abstract][Full Text] [Related]
40. A Sputum Proteomic Signature That Associates with Increased IL-1β Levels and Bacterial Exacerbations of COPD.
Damera G; Pham TH; Zhang J; Ward CK; Newbold P; Ranade K; Sethi S
Lung; 2016 Jun; 194(3):363-9. PubMed ID: 27083436
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
